On the other hand, it was shown that the proportion of CTLA-4+ CD4+ T cells in treatment-naive RRMS and SPMS patients was substantially higher than that in healthy controls and that this difference was more pronounced in RRMS patients. Here, CD4 is linked to secondary progressive multiple sclerosis.